Hereditary Angioedema

← Back to Class List

PDL Status Values

Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the Non-Preferred Drugs in Select PDL Classes prior authorization criteria. New drugs will be listed as N until reviewed by the P&T Committee and are subject to the New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.

To request a Prior Authorization, please use this form.

Alternate detailed view >

Generic Name Brand Name Form PDL
Status
Current Drug Use Criteria Carveout
‐ Bill FFS
New Drug Evaluation & Updates
C1 esterase inhibitor BERINERT KIT Y Medical & Pharmacy PA  
C1 esterase inhibitor BERINERT VIAL Y Medical & Pharmacy PA  
C1 esterase inhibitor HAEGARDA VIAL Y Medical & Pharmacy PA  
icatibant acetate ICATIBANT SYRINGE Y Medical & Pharmacy PA  
berotralstat hydrochloride ORLADEYO CAPSULE N Medical & Pharmacy PA  
berotralstat hydrochloride ORLADEYO PELET PACK N Medical & Pharmacy PA  
C1 esterase inhibitor CINRYZE VIAL N Medical & Pharmacy PA  
C1 esterase inhibitor, recomb RUCONEST VIAL N Medical & Pharmacy PA  
donidalorsen sodium DAWNZERA AUTO INJCT N Medical & Pharmacy PA  
ecallantide KALBITOR VIAL N Medical & Pharmacy PA  
garadacimab-gxii ANDEMBRY AUTOINJECTOR AUTO INJCT N Medical & Pharmacy PA  
icatibant acetate SAJAZIR SYRINGE N Medical & Pharmacy PA  
icatibant acetate FIRAZYR SYRINGE N Medical & Pharmacy PA  
lanadelumab-flyo TAKHZYRO SYRINGE N Medical & Pharmacy PA  
sebetralstat EKTERLY TABLET N Medical & Pharmacy PA